MFSD11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.566600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.627600E-01
Normal-vs-Stage2
5.910600E-01
Normal-vs-Stage3
8.664600E-01
Normal-vs-Stage4
3.891600E-01
Stage1-vs-Stage2
8.418200E-01
Stage1-vs-Stage3
8.049400E-01
Stage1-vs-Stage4
6.845800E-01
Stage2-vs-Stage3
7.973600E-01
Stage2-vs-Stage4
4.557400E-01
Stage3-vs-Stage4
6.322400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.609400E-01
Normal-vs-AfricanAmerican
5.302400E-01
Normal-vs-Asian
8.254800E-01
Caucasian-vs-AfricanAmerican
8.011800E-01
Caucasian-vs-Asian
1.464220E-01
AfricanAmerican-vs-Asian
2.453600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.579400E-01
Normal-vs-Female
4.604200E-01
Male-vs-Female
2.208400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.092400E-01
Normal-vs-Age(41-60Yrs)
2.288800E-01
Normal-vs-Age(61-80Yrs)
7.893000E-01
Normal-vs-Age(81-100Yrs)
6.165600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.364800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.417200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.839600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.802200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.032400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.657200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.909000E-01
Normal-vs-Daily Drinker
8.994000E-01
Normal-vs-Weekly Drinker
8.575400E-01
Normal-vs-Occasional Drinker
3.497600E-01
Normal-vs-Social Drinker
2.738600E-01
Non Drinker-vs-Daily Drinker
6.374200E-01
Non Drinker-vs-Weekly Drinker
3.650800E-01
Non Drinker-vs-Occasional Drinker
3.819200E-01
Non Drinker-vs-Social Drinker
3.177000E-01
Daily Drinker-vs-Weekly Drinker
5.919000E-01
Daily Drinker-vs-Occasional Drinker
1.063200E-01
Daily Drinker-vs-Social Drinker
9.687800E-02
Weekly Drinker-vs-Occasional Drinker
5.476100E-02
Weekly Drinker-vs-Social Drinker
4.158200E-02
Occasional Drinker-vs-Social Drinker
9.864000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.677600E-02
Normal-vs-Grade 2
1.736320E-02
Normal-vs-Grade 3
1.689830E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.287600E-01
Grade 1-vs-Grade 3
1.495600E-02
Grade 1-vs-Grade 4
7.677600E-02
Grade 2-vs-Grade 3
3.382300E-02
Grade 2-vs-Grade 4
1.736320E-02
Grade 3-vs-Grade 4
1.689830E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.252800E-01
Normal-vs-NonDiabetic
5.745400E-01
Diabetic-vs-NonDiabetic
3.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.777600E-01
Normal-vs-NoPancreatitis
6.509000E-01
Pancreatitis-vs-NoPancreatitis
5.087600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.059400E-01
Normal-vs-N1
5.831200E-01
N0-vs-N1
6.310000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.860400E-01
Normal-vs-TP53-NonMutant
6.339200E-01
TP53-Mutant-vs-TP53-NonMutant
1.650640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
